Muscle eosinophilia is a hallmark of chronic disease in facioscapulohumeral muscular dystrophy
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Andreia M Nunes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Nevada, Reno School of Medicine, 1664 N. Virginia St., Reno, NV 89557, United States. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Homeodomain Proteins, Disease Models, Animal, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Facioscapulohumeral muscular dystrophy (FSHD) is a progressive myopathy caused by the aberrant increased expression of the DUX4 retrogene in skeletal muscle cells. The DUX4 gene encodes a transcription factor that functions in zygotic genome activation and then is silenced in most adult somatic tissues. DUX4 expression in FSHD disrupts normal muscle cell function; however, the downstream pathogenic mechanisms are still unclear. Histologically, FSHD affected muscles show a characteristic dystrophic phenotype that is often accompanied by a pronounced immune cell infiltration, but the role of the immune system in FSHD is not understood. Previously, we used ACTA1;FLExDUX4 FSHD-like mouse models varying in severity as discovery tools to identify increased Interleukin 6 and microRNA-206 levels as serum biomarkers for FSHD disease severity. In this study, we use the ACTA1;FLExDUX4 chronic FSHD-like mouse model to provide insight into the immune response to DUX4 expression in skeletal muscles. We demonstrate that these FSHD-like muscles are enriched with the chemoattractant eotaxin and the cytotoxic eosinophil peroxidase, and exhibit muscle eosinophilia. We further identified muscle fibers with positive staining for eosinophil peroxidase in human FSHD muscle. Our data supports that skeletal muscle eosinophilia is a hallmark of FSHD pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Nevada, Reno School of Medicine, 1664 N. Virginia St., Reno, NV 89557, United States.
ORCID-Profile: Peter L Jones
Förderung
- NIAMS NIH HHS
- NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
- University of Nevada, Reno School of Medicine
Zitieren
APA
Nunes, A. M., Ramirez, M. M., Garcia-Collazo, E., Jones, T. I., & Jones, P. L. (2024). Muscle eosinophilia is a hallmark of chronic disease in facioscapulohumeral muscular dystrophy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae019
Vancouver
Nunes AM, Ramirez MM, Garcia-Collazo E, Jones TI, Jones PL. Muscle eosinophilia is a hallmark of chronic disease in facioscapulohumeral muscular dystrophy. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae019
BibTeX
@article{Nunes2024,
author = {Nunes, Andreia M and Ramirez, Monique M and Garcia-Collazo, Enrique and Jones, Takako Iida and Jones, Peter L},
title = {Muscle eosinophilia is a hallmark of chronic disease in facioscapulohumeral muscular dystrophy},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae019}
}
EUVIMED